Clinical outcomes with on‐label and off‐label use of the transcatheter heart valve in the United States
Joel A. Lardizabal(University of Miami), Alan W. Heldman(University of Miami), Carlos Alfonso(Centro de Investigaciones Biológicas Margarita Salas), Conrad Macon(Oregon Health & Science University), Claudia Martinez, William W. O’Neill(Henry Ford Health System), Vikas Singh(University of Miami), Donald B. Williams(University of Miami), Brian O’Neill(Henry Ford Health System), Mauricio G. Cohen(Santa Ana College)
Cited by 4
Related Papers
A Controlled Trial of Renal Denervation for Resistant Hypertension
|New England Journal of Medicine|2014|2.2k
Contemporary Management of Cardiogenic Shock: A Scientific Statement From the American Heart Association
|Circulation|2017|1.8k
2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization
|Journal of the American College of Cardiology|2021|1.5k
A Randomized Trial of Immediate versus Delayed Elective Angioplasty after Intravenous Tissue Plasminogen Activator in Acute Myocardial Infarction
|New England Journal of Medicine|1987|945